Medications

Gilead's Harvoni accepted in Canadian health plan

Gilead Sciences said multiple Canadian provinces will provide access to the biotechnology company's hepatitis C drug Harvoni following a positive reimbursement recommendation from regulators.

Medical research

Lab creates potentially life saving heart cells

A group of Simon Fraser University researchers' cultivation of dozens of beating heart cells in Petrie dishes could one day save or improve the lives of patients with inherited heart arrhythmias. They are genetic mutations ...

Sleep disorders

3-D printed device relieves sleep apnoea

Sleep apnoea is a condition where the air passage in the throat becomes blocked during sleep and causes people to stop breathing.

Pediatrics

Blow to chest may trigger potentially dangerous heart rhythm

A hard hit to the chest can cause an irregular heartbeat that may lead to death even days after the impact, according to an upcoming article in the journal Pediatrics, based on a case involving a 16-year-old Hawai`i football ...

Health

Are the benefits of breast milk stimulant worth the risk?

Most women can make all the milk their baby needs, but some mothers turn to medications to help increase their supply. While some specialists encourage the off-label use of domperidone to stimulate breast milk production, ...

Cardiology

US emergency room visits for irregular heartbeat soar

Emergency room visits for atrial fibrillation have increased significantly in the United States—causing a major healthcare burden, according to research presented at the American Heart Association's Scientific Sessions ...

Cardiology

Grant awarded for device to detect newborn heart problems

Each year, some 2,000 babies are born in the U.S. with a genetic heart condition, known as long QT syndrome. If not diagnosed in time, babies with long QT syndrome can die from a sudden arrhythmia, or irregular heartbeat.

page 12 from 21